

@article {526,
	title = {Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation},
	journal = {Biol Blood Marrow Transplant},
	volume = {7},
	number = {7},
	year = {2001},
	note = {Hoffman, J A Shah, A J Ross, L A Kapoor, N Clinical Trial Journal Article United States Biol Blood Marrow Transplant. 2001;7(7):388-94.},
	pages = {388-94},
	type = {Journal Article},
	abstract = {{Adenoviral (ADV) infections are increasingly recognized as a cause of morbidity and mortality in pediatric hematopoietic stem cell transplantation (HSCT). We reviewed our experience with ADV infections in HSCT patients hospitalized for transplantation at Childrens Hospital Los Angeles January 1998 through December 1998. ADV was detected in 47\% of patients, with recipients of HSCT from alternative donors (matched unrelated, unrelated cord, and mismatched related donors) being more frequently culture positive than recipients of HSCT from matched siblings (62\% versus 27\%},
	keywords = {Adenoviridae Infections/*drug therapy/mortality/pathology Adolescent Adult Antiviral Agents/*administration \& dosage/toxicity Child Child, Homologous/adverse effects/immunology Treatment Outcome, Preschool Cytosine/*administration \& dosage/*analogs \& derivatives/toxicity Female Hematologic Diseases/complications/therapy Hematopoietic Stem Cell Transplantation/*adverse effects Humans Infant Male *Organophosphonates Organophosphorus Compounds/*admi},
	issn = {1083-8791 (Print) 1083-8791},
	author = {Hoffman, J. A. and Shah, A. J. and Ross, L. A. and Kapoor, N.}
}
